TCM
NVO

Teza Capital Management’s Novo Nordisk NVO Stock Holding History

Teza Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,124
Closed -$242K – 253
2017
Q1 		$242K Buy
+14,124
New +$246K 0.07% 395

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Teza Capital Management's NVO Position: Q2 2017 in Review

Teza Capital Management sold out of Novo Nordisk (NVO) in Q2 2017, closing a stake of 14,124 shares — an estimated $242K sold.

Teza Capital Management first reported a position in NVO in Q1 2017 and held it in 1 quarter. The position peaked at $242K in Q1 2017. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Teza Capital Management reported no remaining Novo Nordisk position as of Q2 2017 after selling out during the quarter.
  • Teza Capital Management sold 14,124 Novo Nordisk shares in Q2 2017, an estimated $242K.
  • Teza Capital Management first reported a position in Novo Nordisk in Q1 2017 and held it in 1 quarter.
  • Teza Capital Management's Novo Nordisk position peaked at $242K in Q1 2017.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Teza Capital Management's 13F filing for Q2 2017.